Antonio Ceriello, MD, Appointed Editor-in-Chief, Diabetes Research and Clinical Practice

OXFORD, England, June 30, 2016 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Diabetes Federation (IDF) welcome Professor Antonio Ceriello, MD, as the new Editor-in-Chief of Diabetes Research and Clinical Practice (DRCP), the official journal of IDF, published by Elsevier.

For more than 25 years, DRCP has been an important journal for the publication and promotion of global research and care in diabetes. DRCP is home to the scientific publications that accompany the IDF Diabetes Atlas as well as the results of many ground-breaking randomized clinical trials.

Professor Ceriello will take over from Professor Stephen Colagiuri, MD (University of Sydney), on July 1st. He is affiliated with the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in Barcelona, Spain and the Department of Cardiovascular and Metabolic Diseases at IRCCS MultiMedica in Milan, Italy. Discussing his new appointment, Prof. Ceriello said, "It is a pleasure to serve as Editor-in-Chief of DRCP. I will endeavor to continue the excellent work done by Stephen Colagiuri, supported both by my previous experience as Associate Editor of other prestigious journals and by the team at DRCP."

Retiring Editor-in-Chief Professor Colagiuri commented, "It has been an honor to serve as Editor-in-Chief of DRCP for the past eight years and to see the journal become the official journal of IDF and grow in reputation and impact. I would like to thank the many Associate Editors I have had the good fortune to work with and to welcome Professor Ceriello as the new Editor-in-Chief who I am sure will take the journal to a new level."

IDF President Dr. Shaukat Sadikot said, "IDF is proud that a great deal of our research has been published in DRCP. This journal has published important research on the epidemiology of diabetes, prevention of complications, type 2 diabetes prevention and new classification criteria. We expect that DRCP will continue to be the journal of choice for international health professionals and clinically-oriented scientists who are investigating topics related to diabetes clinical research and patient care."

About Diabetes Research and Clinical Practice:

Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas.

About the International Diabetes Federation: 

The International Diabetes Federation (IDF) is an umbrella organization of over 230 national diabetes associations in 170 countries and territories. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950. http://www.idf.org

About Elsevier: 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. http://www.elsevier.com

Media Contact:
Andrew Miller
Elsevier
+44-186-5843-823
andrew.miller@elsevier.com

SOURCE Elsevier